8-KRegulation FDExhibits & Filings

American Water Works Company, Inc. 8-K Report, Regulation FD Disclosure (May 8, 2023)

Filed May 8, 2023For Securities:AWK

Summary

American Water Works Company, Inc. (AWK) filed an 8-K on May 7, 2023, primarily to disclose its participation in a public hearing with the U.S. Environmental Protection Agency (EPA) on May 4, 2023. The company's Chief Environmental and Safety Officer provided oral comments on the EPA's proposed National Primary Drinking Water Regulation Rulemaking concerning PFAS (per- and polyfluoroalkyl substances). This filing is significant for investors as it highlights AWK's proactive engagement with regulatory bodies on a critical environmental and operational issue. The prepared remarks, furnished as an exhibit, offer insight into the company's perspective on the proposed regulations, potential impacts, and its commitment to ensuring safe drinking water. Investors should review these remarks to understand AWK's strategy in navigating evolving environmental standards and potential compliance costs.

Key Highlights

  • 1AWK's Chief Environmental and Safety Officer provided oral comments to the EPA on proposed PFAS drinking water regulations.
  • 2The company is actively engaging with regulators on significant environmental rulemakings.
  • 3Prepared remarks from the EPA hearing are included as an exhibit, offering detailed insights into AWK's position.
  • 4The filing emphasizes AWK's commitment to water quality and compliance with drinking water standards.
  • 5This engagement is crucial for understanding potential future operational costs and capital expenditures related to PFAS remediation or treatment.

Frequently Asked Questions

The main purpose of this 8-K filing is to inform investors that American Water Works Company, Inc. (AWK) participated in a public hearing with the EPA and presented comments on proposed regulations regarding PFAS in drinking water. The company has also furnished the prepared remarks from this hearing as an exhibit.

PFAS (per- and polyfluoroalkyl substances) are a group of man-made chemicals that have been detected in drinking water across the United States. They are a growing concern due to potential health risks. For AWK, these proposed regulations are important because they could impact the company's water treatment processes, require significant capital investments for new treatment technologies, and potentially lead to increased operational costs.

The prepared remarks delivered by AWK's Chief Environmental and Safety Officer at the EPA public hearing are included as Exhibit 99.1 to this 8-K filing. Investors should review this document for detailed insights into the company's perspective, concerns, and recommendations regarding the proposed PFAS National Primary Drinking Water Regulation.

This specific 8-K filing primarily serves to disclose AWK's participation and provide the prepared remarks. While it doesn't announce immediate financial results or specific charges, the company's engagement suggests that it is preparing for or evaluating the potential financial implications of the proposed PFAS regulations. Investors should monitor future filings and communications for any updates on capital expenditures, operational adjustments, or financial guidance related to PFAS compliance.